RIA
BLCM

Realta Investment Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Realta Investment Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed – – 1506
2019
Q4 		$0 Hold
1
– – ﹤0.01% 1711
2019
Q3 		$0 Hold
1
– – ﹤0.01% 1845
2019
Q2 		$0 Hold
1
– – ﹤0.01% 1835
2019
Q1 		$0 Buy
+1
New +$33 ﹤0.01% 1360

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Realta Investment Advisors's BLCM Position: Q1 2020 in Review

Realta Investment Advisors sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2020, closing a stake of 1 share.

Realta Investment Advisors first reported a position in BLCM in Q1 2019 and held it in 4 quarters. The position peaked at $0 in Q4 2019. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2020.

  • Realta Investment Advisors reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 1 Bellicum Pharmaceuticals, Inc. share in Q1 2020.
  • Realta Investment Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2019 and held it in 4 quarters.
  • Realta Investment Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $0 in Q4 2019.
  • 29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.